Synovus Financial’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$2.54M Buy
7,867
+164
+2% +$51K 0.03% 319
2025
Q2
$3M Sell
7,703
-251
-3% -$101K 0.04% 275
2025
Q1
$3.46M Sell
7,954
-226
-3% -$90.7K 0.04% 243
2024
Q4
$3.02M Sell
8,180
-31
-0.4% -$13K 0.04% 279
2024
Q3
$4.27M Buy
8,211
+40
+0.5% +$21.4K 0.05% 244
2024
Q2
$4.43M Buy
8,171
+10
+0.1% +$5.29K 0.06% 206
2024
Q1
$4.23M Sell
8,161
-15
-0.2% -$7.46K 0.06% 211
2023
Q4
$3.86M Buy
8,176
+26
+0.3% +$12K 0.05% 205
2023
Q3
$3.55M Sell
8,150
-21
-0.3% -$9.53K 0.04% 238
2023
Q2
$3.63M Buy
8,171
+9
+0.1% +$4.15K 0.04% 244
2023
Q1
$3.75M Buy
8,162
+65
+0.8% +$30.9K 0.04% 231
2022
Q4
$4.15M Sell
8,097
-219
-3% -$111K 0.05% 211
2022
Q3
$3.78M Buy
8,316
+52
+0.6% +$24.9K 0.05% 206
2022
Q2
$3.99M Sell
8,264
-28
-0.3% -$13.9K 0.05% 206
2022
Q1
$4.07M Sell
8,292
-6
-0.1% -$2.74K 0.04% 210
2021
Q4
$3.85M Buy
8,298
+223
+3% +$93.8K 0.04% 236
2021
Q3
$3.01M Sell
8,075
-822
-9% -$312K 0.03% 247
2021
Q2
$3.4M Sell
8,897
-257
-3% -$98.2K 0.03% 233
2021
Q1
$3.29M Buy
9,154
+120
+1% +$38.6K 0.04% 213
2020
Q4
$2.9M Sell
9,034
-2,415
-21% -$741K 0.03% 224
2020
Q3
$3.08M Sell
11,449
-195
-2% -$52.5K 0.04% 202
2020
Q2
$3.06M Sell
11,644
-613
-5% -$164K 0.04% 184
2020
Q1
$2.78M Buy
12,257
+839
+7% +$229K 0.04% 217
2019
Q4
$3.45M Sell
11,418
-1,054
-8% -$290K 0.05% 175
2019
Q3
$3M Buy
12,472
+153
+1% +$41.9K 0.05% 176
2019
Q2
$3.47M Buy
12,319
+82
+0.7% +$22.4K 0.05% 163
2019
Q1
$3.51M Sell
12,237
-85
-0.7% -$24.6K 0.06% 160
2018
Q4
$3.23M Sell
12,322
-558
-4% -$153K 0.06% 162
2018
Q3
$3.53M Buy
12,880
+611
+5% +$159K 0.06% 165
2018
Q2
$2.92M Buy
12,269
+116
+1% +$26.9K 0.05% 183
2018
Q1
$2.67M Buy
12,153
+6,239
+105% +$1.47M 0.05% 186
2017
Q4
$1.33M Buy
5,914
+80
+1% +$17K 0.02% 261
2017
Q3
$1.1M Buy
5,834
+119
+2% +$22.6K 0.02% 277
2017
Q2
$1.07M Sell
5,715
-177
-3% -$31.8K 0.02% 286
2017
Q1
$973K Sell
5,892
-373
-6% -$59.3K 0.02% 271
2016
Q4
$895K Sell
6,265
-113
-2% -$15.1K 0.02% 272
2016
Q3
$798K Sell
6,378
-1,093
-15% -$141K 0.02% 280
2016
Q2
$982K Sell
7,471
-194
-3% -$26.5K 0.02% 264
2016
Q1
$1.07M Buy
7,665
+1,560
+26% +$208K 0.03% 250
2015
Q4
$854K Buy
6,105
+1,452
+31% +$200K 0.02% 278
2015
Q3
$651K Sell
4,653
-600
-11% -$90.2K 0.02% 320
2015
Q2
$862K Sell
5,253
-250
-5% -$39.9K 0.02% 292
2015
Q1
$851K Sell
5,503
-80
-1% -$11.4K 0.02% 297
2014
Q4
$699K Buy
5,583
+130
+2% +$16.1K 0.02% 317
2014
Q3
$653K Buy
5,453
+55
+1% +$6.31K 0.02% 313
2014
Q2
$584K Hold
5,398
0.02% 304
2014
Q1
$538K Hold
5,398
0.02% 308
2013
Q4
$493K Sell
5,398
-310
-5% -$27.5K 0.01% 305
2013
Q3
$479K Hold
5,708
0.02% 305
2013
Q2
$465K Buy
+5,708
New +$427K 0.01% 299

Other funds holding ELV